Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05573126
What this trial is testing

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Who this might be right for
Hormone Receptor-positive Breast CancerHormone Receptor Positive HER-2 Negative Breast CancerMetastatic Breast Cancer
Ellipses Pharma 95
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Not applicableLooking for participantsNCT06225505
What this trial is testing

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 450
Large-scale testing (Phase 3)Looking for participantsNCT06268652
What this trial is testing

Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

Who this might be right for
Breast CancerRefractory Breast Carcinoma
Sun Yat-sen University 302
Testing effectiveness (Phase 2)Study completedNCT02541370
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Who this might be right for
Liver CancerPancreatic CancerBrain Tumor+4 more
Chinese PLA General Hospital 20
Not applicableUnknownNCT04130373
What this trial is testing

Multicentric Risk Evaluation of Autologous Fat Grafting Procedure

Who this might be right for
Pain, Postoperative
Humanitas Clinical and Research Center 6,510
Large-scale testing (Phase 3)Active Not RecruitingNCT06760637
What this trial is testing

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Who this might be right for
Breast Cancer
Pfizer 1,035
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Testing effectiveness (Phase 2)UnknownNCT05464173
What this trial is testing

Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib

Who this might be right for
Breast Cancer
Biyun Wang, MD 44
Early research (Phase 1)Study completedNCT02009631
What this trial is testing

Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

Who this might be right for
Breast CancerOvarian CancerColon Cancer+3 more
AbbVie 45
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Testing effectiveness (Phase 2)Looking for participantsNCT04985266
What this trial is testing

A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Who this might be right for
ER+ Breast CancerHER2-negative Breast Cancer
Royal Marsden NHS Foundation Trust 1,100
Testing effectiveness (Phase 2)UnknownNCT04739670
What this trial is testing

Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

Who this might be right for
Metastatic Triple Negative Breast Cancer
Peter MacCallum Cancer Centre, Australia 31
Testing effectiveness (Phase 2)Looking for participantsNCT06518837
What this trial is testing

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Rutgers, The State University of New Jersey 40
Not applicableLooking for participantsNCT07180693
What this trial is testing

Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:

Who this might be right for
Adjuvant TherapyCDK4/6 Inhibitor
European Institute of Oncology 750
Not applicableStudy completedNCT01279304
What this trial is testing

Radiotherapy After Primary Chemotherapy for Breastcancer

Who this might be right for
Breast Cancer
Maastricht Radiation Oncology 851
Large-scale testing (Phase 3)Study completedNCT00074152
What this trial is testing

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 162
Large-scale testing (Phase 3)Study completedNCT03371017
What this trial is testing

The Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Hoffmann-La Roche 595
Next Page